Q3 sales are down by 12% compared with Q3 2024 and by some 35% compared with the previous quarter at SEK 8.0m. Recurring sales are also softer by some 28% vs Q2 2024, even if 12m trailing sales remains stable at SEK 40-42m. The main reason for the soft Q3 sales contribution seems to be the Irish HSE re-organisation (a shift towards regional management) and a quarter with modest contribution from virtual wards and Coala (US). As a result, the near-term sales outlook is more uncertain.
LÄS MER